Gunnbjorg Hjeltnes
Lillehammer, 2819, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies.
Journal: Journal of clinical medicine
Published: October 12, 2022
Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis.
Journal: PloS one
Published: July 13, 2021
Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
Journal: PloS one
Published: April 20, 2021
Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
Journal: PloS one
Published: March 18, 2021
Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study.
Journal: PloS one
Published: March 24, 2019
Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis.
Journal: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
Published: March 13, 2018
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis.
Journal: Arthritis research & therapy
Published: May 23, 2017
Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Journal: PloS one
Published: September 21, 2016
Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 11, 2014
Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.
Journal: Clinical and experimental rheumatology
Published: August 08, 2012
Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-α inhibitors.
Journal: The Journal of rheumatology
Published: June 05, 2012
Endothelial function improves within 6 weeks of treatment with methotrexate or methotrexate in combination with a TNF-α inhibitor in rheumatoid arthritis patients.
Journal: Scandinavian journal of rheumatology
Published: March 10, 2012
Last Updated: 09/26/2026